AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BOIRON Interim / Quarterly Report 2016

Oct 20, 2016

1161_10-q_2016-10-20_a797dbc5-5e73-47fd-8f0e-3a23937fae5c.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

ACTIVITY IN THE THIRD QUARTER OF 2016 (Unaudited data)

DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)

	st quarter 1			nd quarter 2			rd quarter 3
thousands of euros	2015	2016	Var.	2015	2016	Var.	2015	2016	Var.
			16/15			16/15			16/15
France	89,584	90,494	+1.0%	76,864	80,469	+4.7%	97,767	98,840	+1.1%
Europe (excluding France)	40,657	43,685	+7.4%	29,943	31,572	+5.4%	50,614	41,273	-18.5%
North America	17,193	16,064	-6.6%	12,894	14,113	+9.5%	16,055	16,020	-0.2%
Other countries	4,622		3,846 -16.8%	3,816	4,061	+6.4%	3,594	3,280	-8.7%
Group total	152,056	154,089	+1.3%	123,517	130,215	+5.4%	168,030	159,413	-5.1%
	st quarter nd quarter 1 2				rd quarter 3
thousands of euros	2015	2016	Var.	2015	2016	Var.	2015	2016	Var.
			16/15			16/15			16/15
Non-proprietary Homeopathic Medicines	79,191	80,147	+1.2%	74,354	76,001	+2.2%	73,677	73,913	+0.3%
OTC Specialties	72,880	73,743	+1.2%	49,030	53,719	+9.6%	94,328	85,319	-9.6%
Other	-15	199	-	133		495 +272.2%	25		181 +624.0%
Group total	152,056	154,089	+1.3%	123,517	130,215	+5.4%	168,030	159,413	-5.1%

CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2016

thousands of euros	2015	2016	Variation at current exchange rates	Variation at constant exchange rates
France	264,215	269,803	+2.1%	+2.1%
Europe (excluding France)	121,214	116,530	-3.9%	-1.0%
North America	46,142	46,197	+0.1%	+0.9%
Other countries	12,032	11,187	-7.0%	-4.3%
Group total	443,603	443,717	+0.0%	+1.0%

	2015	2016	Variation at	Variation at
thousands of euros			current	constant
			exchange	exchange
			rates	rates
Non-proprietary Homeopathic Medicines	227,222	230,061	+1.2%	+1.3%
OTC Specialties	216,238	212,781	-1.6%	+0.3%
Other	143	875	+511.9%	+511.9%
Group total	443,603	443,717	+0.0%	+1.0%

● HIGHLIGHTS OF THE THIRD QUARTER

Sales revenue in the third quarter of 2016 was down by 5.1% in comparison to 2015 (the impact of exchange rates is not significant over the period).
Sales are decreasing significantly in Russia and to a lesser extent in Spain and in the Czech Republic. They are increasing in France.

● OUTLOOK

The level of activity and profitability of the fiscal year will depend on the seasonal pathology of the fourth quarter.
Our company still continues with the same determination the development of homeopathy in the world.

Our next update: January 26, 2017 at market close, publication of the sales revenue for the year 2016. Person responsible for financial information: Christian Boiron Contact for financial information: Véronique Bouscayrol Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected] ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA The group's financial information is online at: www.boironfinance.com